Preclinical study identifies possible therapeutic target for cardiovascular risk factors that avoid the common problem of an increased risk of fatty liver disease.

Bad air isn’t just a nuisance; it’s believed to contribute to heart disease. And the risk isn’t only found in those heavily polluted cities seen on the news.